Tectonic Therapeutic (NASDAQ: TECX) had its price target lowered by analysts at Wells Fargo & Company from $112.00 to $101.00. They now have an "overweight" rating on the stock.
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Tectonic Therapeutic to Participate in March Investor Conferences
Tectonic Announces $185 Million Private Placement [Yahoo! Finance]
Tectonic Announces $185 Million Private Placement